Neurotoxicity of taxanes: symptoms and quality of life assessment.
about
Exercise for preventing falls in people with cancer living in the communityResidual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.Microtubule-binding agents: a dynamic field of cancer therapeutics.Neuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy.Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer.The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients.Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.Tai Ji Quan for the aging cancer survivor: Mitigating the accelerated development of disability, falls, and cardiovascular disease from cancer treatmentOmega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.Comparison of tai chi vs. strength training for fall prevention among female cancer survivors: study protocol for the GET FIT trial.Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational studyBreast cancer medications and vision: effects of treatments for early-stage disease.Paclitaxel causes degeneration of both central and peripheral axon branches of dorsal root ganglia in miceCR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Identifying factors associated with falls in postmenopausal breast cancer survivors: a multi-disciplinary approach.A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.Occupational Therapy for Adults With Cancer: Why It Matters.Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376)Mechanisms of the analgesic effect of calcitonin on chronic pain by alteration of receptor or channel expression.NMR-Based Metabolic Profiling Reveals Neurochemical Alterations in the Brain of Rats Treated with Sorafenib.Comparison of the Effects of Omega 3 and Vitamin E on Palcitaxel-Induced Peripheral Neuropathy
P2860
Q24188304-593A23B4-B8C7-4280-917B-A4F417A2F99AQ25257587-68DBBE33-7270-4375-8F3A-82ECB0096027Q27690249-CE2E3281-D103-4095-BB1E-FC96F9C7DE00Q33815594-BE32D8C5-DE15-418D-B71D-BFE992AA4F8DQ33885675-DD97D3FD-8144-4568-8AF3-DDDCC33478E1Q33982653-63C4C76E-1D83-46F4-B20C-8CB079A052D3Q34039871-64DBF225-1976-4028-AA80-9A92A9BD1450Q34267694-D4978FFE-1FBD-4458-9AB6-077B6E79203DQ34380579-7ACC9343-01EC-4804-BA99-28A70B1C736AQ34384978-8288325A-F868-4A9A-B184-7A707AC8A912Q34502776-5E6F09DC-4371-4869-B9FA-2D027809D281Q34552660-2F7966B9-0699-4158-A0A5-E3C8E7A2E6DDQ34843961-9C7ACEDD-18C9-4530-A499-3E73032FB87FQ35496778-8B7F9DF1-843A-476A-952A-F4C2AB30C68FQ36073032-F898C8B6-C4E9-4406-83A4-0FBFC5CF824AQ36084704-407E24F1-7C4E-4387-B0CC-4E59647267FAQ36198723-89A05E42-D872-4076-85F4-B05D7F1B6DBCQ36243420-31913501-8609-456A-93FC-00F9793ED42AQ36673481-4CB16AAA-95DE-4D71-BEDF-05C1D5243BEBQ36877796-5AFFFC2F-99AF-4CA8-BBAA-A8AD8FE80E42Q37348953-A0A1383F-529C-471A-9908-36FD75A7CF24Q38670761-114AFBDB-F989-461D-BD98-30D7F6DAE1D6Q40669763-1F1EDEB6-9DAB-434A-879A-C9CDA616EE21Q59136704-2D160D1B-BEA3-4A7A-AE41-B1A8C4B1440D
P2860
Neurotoxicity of taxanes: symptoms and quality of life assessment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@ast
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@en
type
label
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@ast
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@en
prefLabel
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@ast
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@en
P2860
P356
P1433
P1476
Neurotoxicity of taxanes: symptoms and quality of life assessment.
@en
P2093
Katsumasa Kuroi
Kojiro Shimozuma
P2860
P2888
P356
10.1007/BF02968010
P577
2004-01-01T00:00:00Z